Anebulo Pharmaceuticals, Inc. (ANEB): Shareholders' Equity
$11.66M
As of 2025-06-30
$7.94M
As of 2025-12-31
-8.2%
3-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-06-30 | $11.66M | +205.8% | 2025-09-29, Balance as of period end |
| 2024-06-30 | $3.81M | -64.0% | 2025-09-29, Balance as of period end |
| 2023-06-30 | $10.60M | -29.6% | 2024-09-25, Balance as of period end |
| 2022-06-30 | $15.07M | -29.6% | 2023-09-22, Balance as of period end |
| 2021-06-30 | $21.41M | n/m | 2022-09-09, Balance as of period end |
| 2020-06-30 | -$171.1K | n/a | 2021-09-22, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Anebulo Pharmaceuticals, Inc. (ANEB) | 2025-06-30 | $11.66M | +205.8% |
| Turn Therapeutics Inc. (TTRX) | 2025-12-31 | $4.69M | n/m |
| Imunon, Inc. (IMNN) | 2025-12-31 | $7.06M | +66.4% |
| PRF Technologies Ltd. (PRFX) | 2025-12-31 | $8.54M | +368.4% |
| Nomad Power Solutions, Inc. (NMAD) | 2025-12-31 | $9.66M | n/m |
| Revelation Biosciences, Inc. (REVB) | 2025-12-31 | $8.86M | +88.2% |
| Curanex Pharmaceuticals Inc (CURX) | 2025-12-31 | $11.22M | n/m |
| Propanc Biopharma, Inc. (PPCB) | 2026-06-30 | $9.40M | -32.4% |
| PMGC Holdings Inc. (ELAB) | 2025-12-31 | $7.84M | +17.7% |
Compare ANEB, TTRX, IMNN, PRFX side by side · Screen every company in Pharmaceutical Preparations ↗